Carlos Eduardo Estrada De La Rosa | Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by World Top Scientists

Dr. Carlos Eduardo Estrada De La Rosa | Toxicology and Pharmaceutical Science | Research Excellence Award

Profesor | Instituto Jalisciense de Alivio al Dolor y Cuidados Paliativos | Mexico

Dr Carlos Eduardo Estrada De La Rosa is a senior pharmaceutical and public health researcher serving as Head of Pharmaceutical Services and Pharmacovigilance and Professor-Researcher at the Instituto Jalisciense de Alivio al Dolor y Cuidados Paliativos, with expertise in pharmacovigilance, hospital pharmacy, medication safety, pain management, and palliative care. He holds advanced training in pharmaceutical sciences, quality assurance, healthcare administration, public health, and doctoral-level specialization in health systems, complemented by international clinical and hospital practice experience. His professional career spans leadership roles in public health institutions, hospitals, and the pharmaceutical industry, where he has led quality systems, medication safety programs, and pharmacovigilance strategies. His research focuses on safe and rational medication use, optimization of pharmacotherapy in palliative care, opioid stewardship, patient safety models, and emerging therapeutic guidelines, with sustained contributions through national and international scientific presentations and applied clinical research. He has received multiple recognitions for advancing patient safety, served on expert panels, contributed to national therapeutic guidelines, and holds leadership memberships in prominent professional and scientific organizations.


View ORCID Profile


Featured Publications

 

Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Assistant Professor | Sandip Institute of Pharmaceutical Sciences | India

Dr. Meghraj Vivekanand Suryawanshi is an accomplished Associate Professor and Training & Placement Coordinator at the Sandip Institute of Pharmaceutical Sciences, Nashik, specializing in pharmaceutics. He holds a Ph.D. in Pharmaceutics from Jaipur National University, an M.Pharm in Pharmaceutics from R.C. Patel Institute of Pharmaceutical Education and Research, a B.Pharm from Sinhgad Institutes of Pharmaceutical Sciences, and an MBA in Hospital Administration. Dr. Suryawanshi has extensive professional experience, serving as a Ph.D. research scholar, Assistant Professor at multiple institutions, and co-founder and CTO of AllWell Nutritech LLP, where he contributed to start-up incubation and entrepreneurial initiatives. He has supervised numerous undergraduate and postgraduate students and actively coordinated academic and administrative programs including training and placement, entrepreneurship, library management, and examination coordination. His research focuses on advanced drug delivery systems, formulation development, and pharmaceutical technology, with a significant body of publications contributing to national and international journals. Dr. Suryawanshi has also engaged in editorial responsibilities and professional memberships that support scholarly exchange and innovation in the pharmaceutical sciences. Recognized for his dedication to research, education, and mentorship, he has been instrumental in fostering academic excellence, student development, and industry collaboration, demonstrating leadership, scientific rigor, and a commitment to advancing the field of pharmaceutics at both institutional and broader professional levels.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Suryawanshi, I., Srinidhi, S., Singh, S., Kalia, R., Kunchala, R. K., Mudavath, S. L., …. (2021). Downshifting and upconversion dual mode emission from lanthanide doped GdPO4 nanorods for unclonable anti-counterfeiting. Materials Today Communications, 26, 102144.

2. Patil, S. M., Suryawanshi, M. V., Chandanshive, V. V., Kurade, M. B., Govindwar, S. P., …. (2020). Regeneration of textile wastewater deteriorated microbial diversity of soil microcosm through bioaugmentation. Chemical Engineering Journal, 380, 122533.

3. Suryawanshi, M. V., Gujarathi, P. P., Mulla, T., & Bagban, I. (2024). Hypericum perforatum: A comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative disorders. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397(6), 3803–3818.

4. Bhagat, D. S., Suryawanshi, I. V., Gurnule, W. B., Sawant, S. S., & Chavan, P. B. (2021). Greener synthesis of CuO nanoparticles for enhanced development of latent fingerprints. Materials Today: Proceedings, 36, 747–750.

5. Suryawanshi, I., Kalia, R., Kunchala, R. K., Mudavath, S. L., & Naidu, B. S. (2022). Detection of latent fingerprints using luminescent Gd0.95Eu0.05PO4 nanorods. Journal of Rare Earths, 40(4), 572–578.

Anthony Mullin | Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Mr. Anthony Mullin | Pharmaceutical Science | Best Researcher Award

PhD Research Molecular Biology, University of Hertfordshire, United Kingdom

Anthony James Mullin is a dedicated researcher with a profound passion for advancing knowledge in tissue culture management and forensic analytical chemistry. His strong academic background and extensive experience in both research and commercial settings make him a vital contributor to the fields of cancer research and psychoactive substance analysis.

Profile

Orcid

Strengths for the Award

Anthony Mullin demonstrates a solid foundation of research expertise, particularly in areas such as psychopharmacology, drug misuse, and analytical chemistry. His work, especially in forensic analysis and the study of New Psychoactive Substances (NPS), reflects innovative approaches, such as applying AI for historical drug misuse trend analysis. His collaboration with renowned researchers like Professor Schifano and Dr. Guirguis further highlights his contributions. Mullin’s research has been recognized at international conferences, underscoring its impact and relevance. His Oxford Press Award for Outstanding Achievements in Bioscience adds to his credibility. Mullin’s well-rounded skill set, including tissue culture management and advanced drug stability analysis, combined with his technical proficiency (e.g., UHPLC, GCMS) and multidisciplinary publications, strengthens his candidacy for the award.

Areas for Improvement

While Mullin’s research portfolio is impressive, his Research Influence (RI) score of 7.0 could benefit from more citations to increase visibility and impact within the academic community. His work, although influential in niche areas, might gain broader recognition by focusing on publishing in higher-impact journals and increasing collaboration beyond his current research groups. Additionally, more outreach and involvement in global networks could amplify his contributions. Although he has presented at international conferences, consistent engagement with the wider research community through more frequent publications and presentations could enhance his profile.

Education 🎓

Anthony graduated with a 1st Class BSc (Hons) in Chemical Biology from the University of Hertfordshire in 2012. His remarkable academic performance earned him the prestigious Oxford Press Award for Outstanding Achievements in Bioscience, underscoring his commitment to excellence in the field of biosciences.

Experience 💼

Anthony has served as a Freelance Research Assistant and Author at the University of Hertfordshire and Swansea University, where he worked within the Psychopharmacology, Drug Misuse, and NPS research group. His previous roles include Research Assistant and Laboratory Technician at the University of Hertfordshire, as well as positions in scientific recruitment and quality control analysis. His diverse experience has equipped him with a unique skill set that bridges the gap between scientific research and practical application.

Research Interests 🔬

Anthony’s research interests are centered around tissue culture management, bio-assay development, and the forensic analysis of new psychoactive substances (NPS). He is particularly interested in utilizing artificial intelligence to enhance analytical methodologies and improve drug stability testing processes.

Awards 🏆

Anthony has received several accolades, including the Oxford Press Award for Outstanding Achievements in Bioscience for his exceptional academic performance. His contributions to research have also led to presentations at prestigious conferences, further establishing him as a respected figure in his field.

Publications Top Notes 📝

  1. Mullin, A., Scott, M., Vaccaro, G., Floresta, G., Arillotta, D., Catalani, V., Corkery, J.M., Stair, J.L., Schifano, F., Guirguis, A. (2024). Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques. Pharmacy 12, 13.
    • Citations: 0
  2. Mullin, A., Scott, M., Vaccaro, G., Gittins, R., Ferla, S., Schifano, F., Guirguis, A. (2023). Handheld Raman Spectroscopy in the First UK Home Office Licensed Pharmacist-Led Community Drug Checking Service. Int. J. Environ. Res. Public Health 20, 4793.
    • Citations: 3
  3. Williams D T, Straw N, Townsend M, Wilkinson A S, and Mullin, A. (2013). Monitoring oak processionary moth Thaumetopoea processionea L. using pheromone traps: the influence of pheromone lure source, trap design and height above the ground on capture rates. Agricultural and Forest Entomology 15, pp.126–134.
    • Citations: 20

Conclusion

Anthony Mullin is a promising researcher with significant achievements in psychopharmacology, drug misuse, and analytical chemistry. His technical skills, innovative approaches, and notable academic accomplishments make him a strong candidate for the “Best Researcher Award.” With targeted efforts to increase the visibility and impact of his work, particularly through citations and global collaboration, Mullin could further solidify his standing in the research community